Dr. Luigina Guasti, University of Insubria, Head, Internal Medicine 1 Unit, Varese, Italy
Dr. Peng Miao, Chinese Academy of Sciences, Suzhou Institute of Biomedical Engineering and Technology, China
Dr. Chaoqun Zhang, South China Agricultural University, China
Submit manuscript at www.itmedicalteam.pl/submissions/translational-biomedicine.html or send as an e-mail attachment to the Editorial Office at [email protected]
Aim and Scope
Translational Biomedicine is an international open access*, peer-reviewed academic journal with Journal Impact Factor 1.12. The Journal publishes original science-based research that advances communication between the scientific discovery and health improvement.
The journal covers the advancement intranslational medicine,molecular medicine, translational genomics,clinical genetics, Translational research & clinical intervention, Translational stroke, Translational Neuroscience, Translational Oncology, Cardiovascular science, Stem cellTranslational Medicineetc.
Translational Biomedicine is indexed and abstracted in the following databases:
Scimago, CiteFactor, SciLit, DeepDyve, Genamics JournalSeek, CrossRef, Journal TOC, Open J-Gate, Electronic Journals Library and many more.
Translational Biomedicine publishes original research or commentary on diseases with implications for treatment, where scientific ideas are translated into clinic trials or applications. Commentary on policy, regulation, education, legal and other issues, national or global medical bioinformation.
Translational Biomedicine welcomes research articles, case reports, comprehensive/mini reviews and short communications from basic sciences to clinical sciences.
Fast Editorial Execution and Review Process (FEE-Review Process):
Translational Biomedicine is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Translational Biomedicine have been cited by esteemed scholars and scientists all around the world. Translational Biomedicine has got h-index 12 , which means every article in Translational Biomedicine has got 12 average citations.